ÂÜÀòÂÒÂ×

Keith Jarvis recently joined Velocity Sciences in January 2022.

His previous role was Senior Director of Process Chemistry at Editas Medicine where he led a large multifaceted team that was responsible for high throughput small scale guide RNA production, the development of novel chemical modifications to enhance delivery, guide RNA process development and large scale GMP manufacturing.

He has also led other oligonucleotide related process development and production groups at several biotechnology companies including Ribozyme Pharmaceuticals, Sirna Therapeutics, Merck Research Laboratories and miRagen Therapeutics.

He received his Bachelor of Science degree in Chemistry from the University of North Carolina at Chapel Hill and his Master of Science Degree from the University of Colorado at Boulder.